In Historic Decision, FDA Approves Cannabidiol, Epidiolex, for Dravet and Lennox-Gastaut
The U.S. Food and Drug Administration has approved Epidiolex to treat Dravet and Lennox-Gastaut syndromes, making history as the first therapy approved to treat Dravet, as well as the first marijuana-derived treatment to receive FDA approval for any indication. GW Pharmaceutical‘s plant-derived cannabinoid medicine was approved to…